1 Day
Source:
The New York Times
FDA Evaluates Peptides for Use
The agency is evaluating whether compound pharmacies should be permitted to produce peptides such as BPC-157 and TB-500, which were previously banned.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)